Staminol

February 2016: A federal judge granted the parties’ request to enter judgment in favor of GNC pursuant to the December 2015 order because the plaintiff did not and does not intend to file an amended complaint.

December 2015: A federal judge granted GNC’s motion to dismiss all of the claims. The judge dismissed claims related to Staminol being used as a product to treat prostate and urinary issues because the complaint did not allege that the named plaintiff purchased the product for such purposes. In addition, a California state law claim was dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled. because the named plaintiff failed to allege a “plausible” claim.

November 2015: A class-action lawsuit was filed against GNC (and transferred to another court in January 2015) for allegedly falsely representing that Staminol, a dietary supplement for men, increases male sexual performance and vitality and treats prostate and urinary flow issues without scientific evidence to support such claims and without FDA approval. (Vigil et al v. General Nutrition Corporation, Case No. 15-cv-00079, S. D. CA.).

For more information about other class-action lawsuits filed against GNC and TINA.org’s coverage of the company, click here.